HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 33 filers reported holding HORIZON PHARMA INVT LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,729,000 | -78.3% | 1,400,000 | -87.0% | 0.00% | -100.0% |
| Q1 2020 | $12,560,000 | -33.6% | 10,785,000 | -24.2% | 0.00% | 0.0% |
| Q4 2019 | $18,920,000 | +29.5% | 14,225,000 | +13.3% | 0.00% | 0.0% |
| Q3 2019 | $14,605,000 | +7.0% | 12,550,000 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $13,653,000 | +3.3% | 12,250,000 | +5.2% | 0.00% | 0.0% |
| Q1 2019 | $13,215,000 | +8.3% | 11,650,000 | -4.5% | 0.00% | 0.0% |
| Q4 2018 | $12,198,000 | -4.0% | 12,200,000 | -3.4% | 0.00% | 0.0% |
| Q3 2018 | $12,705,000 | +4.2% | 12,625,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,189,000 | +5.1% | 12,625,000 | +0.4% | 0.00% | 0.0% |
| Q1 2018 | $11,595,000 | +0.9% | 12,575,000 | +2.4% | 0.00% | 0.0% |
| Q4 2017 | $11,488,000 | +97.7% | 12,275,000 | +91.1% | 0.00% | 0.0% |
| Q3 2017 | $5,812,000 | – | 6,425,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 38,000,000 | $36,741,000 | 4.83% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 82,600,000 | $80,123,000 | 3.73% |
| Context Capital Management, LLC | 2,920,000 | $2,833,000 | 2.75% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 42,250,000 | $40,850,000 | 1.87% |
| LINDEN ADVISORS LP | 33,991,000 | $33,040,000 | 1.51% |
| Nicholas Investment Partners, LP | 11,085,000 | $10,718,000 | 0.71% |
| Jabre Capital Partners S.A. | 4,900,000 | $4,759,000 | 0.65% |
| OAKTREE CAPITAL MANAGEMENT LP | 48,360,000 | $47,069,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 17,578,000 | $17,102,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,284,000 | $6,114,000 | 0.22% |